Rapid dynamic changes of FL.2 variant : a case report of COVID-19 breakthrough infection

Loading...
Thumbnail Image

Authors

Choga, Wonderful T.
Kurusa (Gasenna), Gobuiwang Khilly
San, James Emmanuel
Ookame, Tidimalo
Gobe, Irene
Chand, Mohammed
Phafane, Badisa
Seru, Kedumetse
Matshosi, Patience
Zuze, Boitumelo

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

We investigated intra-host genetic evolution using two SARS-CoV-2 isolates from a fully vaccinated (primary schedule x2 doses of AstraZeneca plus a booster of Pfizer), >70-year-old woman with a history of lymphoma and hypertension who presented a SARS-CoV-2 infection for 3 weeks prior to death due to COVID-19. Two full genome sequences were determined from samples taken 13 days apart with both belonging to Pango lineage FL.2: the first detection of this Omicron sub-variant in Botswana. FL.2 is a sub-lineage of XBB.1.9.1. The repertoire of mutations and minority variants in the Spike protein differed between the two time points. Notably, we also observed deletions within the ORF1a and Membrane proteins; both regions are associated with high T-cell epitope density. The internal milieu of immune-suppressed individuals may accelerate SARS-CoV-2 evolution; hence, close monitoring is warranted.

Description

AVAILABILITY OF DATA AND MATERIALS : The figures and tables of the study are included in the manuscript. The FASTA files are deposited in the Global Initiative on Sharing All Influenza Data (GISAID) database https://doi.org/10.55876/gis8.230821xh : Day-08 is EPI_ISL_17601323[hCoV-19/Botswana/BHP_0123017470/2023], and Day-21 is EPI_ISL_17601322[hCoV-19/Botswana/BHP_1100219671/2023].

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Evolution, Pango lineage FL.2, Immunocompromised, Botswana, FL.2, SDG-03: Good health and well-being

Sustainable Development Goals

SDG-03:Good heatlh and well-being

Citation

Choga, W.T., Kurusa (Gasenna), G.K., San, J.E. et al. 2024, 'Rapid dynamic changes of FL.2 variant : a case report of COVID-19 breakthrough infection', International Journal of Infectious Diseases, vol. 138, pp. 91-96, doi : 10.1016/j.ijid.2023.11.011.